Table 1.
Sex | Age | Electrolyte Abnormalities | ECG Alterations | Clinical Presentation | Aldosterone (pmol/L) | Cortisol (nmol/L) | Serum GA Levels (ng/mL) | Outcome | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hyper-natremia | Hypokalemia | Metabolic Alkalosis | Muscle Disorders | Neurological | MACEs | GI Disorders | Hypertension | Hospital Admission | Death | |||||||
Gross et al., 1966 [7] | F | 45 | NO | YES | YES | YES | YES | NO | NO | NO | NO | N/A | N/A | N/A | YES | NO |
Conn et al., 1968 [8] | M | 58 | YES | YES | YES | N/A | N/A | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Tourtelotte et al., 1970 [9] | F | 63 | NO | YES | N/A | YES | YES | NO | NO | YES | YES | N/A | N/A | N/A | YES | NO |
Holmes et al., 1970 [10] | M | 63 | YES | YES | N/A | YES | YES | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Bannister et al., 1977 [11] | F | 58 | NO | YES | N/A | YES | YES | NO | YES | NO | YES | N/A | N/A | N/A | YES | NO |
Cumming et al., 1980 [12] | F | 70 | NO | YES | NO | N/A | YES | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Nightingale et al., 1981 [13] | F | 25 | NO | YES | YES | YES | YES | NO | NO | YES | NO | N/A | N/A | N/A | YES | NO |
Sundaram et al., 1981 [14] | F | 33 | NO | YES | N/A | NO | NO | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Cibelli et al., 1984 [15] | M | 48 | NO | YES | N/A | YES | YES | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Nielsen et al., 1984 [16] | F | 20 | NO | YES | YES | YES | YES | NO | NO | NO | NO | N/A | N/A | N/A | YES | NO |
Farese et al., 1991 [17] | M | 70 | NO | YES | N/A | N/A | YES | NO | NO | NO | NO | N/A | N/A | N/A | YES | NO |
Kageyama 1992 [18] | M | 54 | NO | YES | N/A | N/A | NO | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Van Der Zwan 1993 [19] | M | 15 | NO | NO | NO | YES | YES | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Heikens et al., 1995 [20] | F | 40 | YES | YES | YES | N/A | NO | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Barella et al., 1997 [21] | M | 61 | N/A | YES | N/A | YES | YES | NO | NO | NO | YES | 95 | N/A | N/A | YES | NO |
Chamberlain et al., 1997 [22] | M | 64 | NO | YES | N/A | NO | NO | NO | NO | NO | N/A | N/A | N/A | N/A | YES | NO |
De Klerk et al., 1997 [23] | F | 21 | NO | YES | N/A | N/A | NO | NO | NO | NO | YES | 160 | N/A | N/A | NO | NO |
De Klerk et al., 1997 [23] | F | 35 | NO | YES | N/A | N/A | NO | NO | NO | NO | YES | 80 | N/A | N/A | NO | NO |
Hasegawa et al., 1998 [24] | M | 65 | NO | YES | YES | YES | YES | NO | YES | NO | NO | <25 | N/A | N/A | YES | NO |
Erikson et al., 1999 [25] | F | 44 | NO | YES | N/A | YES | YES | NO | NO | NO | YES | 4200 | N/A | N/A | NO | NO |
Russo et al., 1999 [26] | M | 42 | NO | YES | N/A | N/A | NO | YES | NO | NO | YES | 180 | N/A | N/A | YES | NO |
Russo et al., 1999 [26] | M | 46 | NO | YES | YES | YES | NO | YES | NO | NO | YES | N/A | N/A | N/A | NO | NO |
Lozano et al., 2000 [27] | F | 34 | NO | YES | N/A | YES | NO | NO | NO | NO | NO | 68 | 14.5 | N/A | YES | NO |
Dobbins et al., 2000 [28] | M | 62 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | NO | NO |
Dobbins et al., 2001 [28] | M | 76 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | NO | NO |
Dobbins et al., 2002 [28] | F | 26 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | NO | NO |
Dobbins et al., 2003 [28] | M | 65 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | NO | NO |
Dobbins et al., 2004 [28] | M | 39 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | NO | NO |
Elinav et al., 2003 [29] | M | 36 | N/A | YES | N/A | YES | YES | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Lin S. et al., 2003 [30] | M | 76 | YES | YES | YES | N/A | YES | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Hall et al., 2004 [31] | F | 62 | N/A | N/A | N/A | N/A | NO | NO | NO | NO | YES | N/A | N/A | N/A | NO | NO |
Janse et al., 2005 [32] | F | 85 | NO | YES | N/A | N/A | NO | YES | NO | NO | YES | 30 | N/A | N/A | YES | NO |
Van Den Bosch et al., 2005 [33] | M | 59 | YES | YES | YES | N/A | YES | YES | NO | NO | YES | 1.48 | N/A | 257 | YES | NO |
Breidthardt et al., 2006 [34] | N/A | 67 | NO | YES | N/A | N/A | NO | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Hamidon et al., 2006 [35] | M | 31 | YES | NO | YES | N/A | YES | YES | NO | NO | YES | N/A | 420 | N/A | YES | NO |
Yasue et al., 2007 [36] | F | 93 | NO | YES | YES | YES | YES | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Francini-Pesenti et al., 2008 [37] | F | 39 | NO | YES | N/A | N/A | YES | YES | NO | YES | NO | 15.08 | N/A | N/A | YES | NO |
Mumoli et al., 2008 [38] | M | 55 | N/A | YES | YES | YES | YES | NO | NO | NO | NO | 60 | N/A | N/A | YES | NO |
Sontia et al., 2008 [39] | F | 55 | YES | YES | N/A | N/A | NO | NO | NO | NO | YES | 31 | N/A | N/A | NO | NO |
Tancevsky et al., 2008 [40] | F | 54 | N/A | YES | N/A | YES | NO | YES | NO | NO | N/A | N/A | N/A | N/A | YES | NO |
Meltem et al., 2009 [41] | M | 21 | NO | YES | NO | NO | YES | NO | NO | NO | NO | N/A | N/A | N/A | YES | NO |
Crean et al., 2009 [42] | F | 71 | NO | YES | N/A | YES | NO | NO | YES | NO | NO | N/A | N/A | N/A | YES | NO |
Johns 2009 [43] | F | 49 | NO | NO | NO | N/A | YES | NO | YES | NO | NO | N/A | N/A | N/A | NO | NO |
Murphy et al., 2009 [44] | F | 64 | NO | YES | N/A | NO | NO | NO | NO | NO | YES | 60 | N/A | N/A | NO | NO |
Yorgun et al., 2010 [45] | F | 50 | NO | YES | NO | YES | YES | YES | YES | NO | YES | N/A | N/A | N/A | YES | NO |
Katchanov et al., 2010 [46] | M | 70 | NO | YES | YES | N/A | YES | NO | NO | NO | YES | 75 | N/A | N/A | YES | NO |
Velickovic-Radovanovic et al., 2010 [47] | F | 39 | NO | YES | NO | YES | YES | NO | NO | YES | YES | 14.28 | N/A | N/A | YES | NO |
Støving et al., 2010 [48] | F | 18 | NO | YES | NO | NO | NO | NO | NO | NO | NO | <25 | N/A | N/A | YES | NO |
Kasap et al., 2010 [49] | M | 16 | NO | YES | YES | YES | YES | NO | NO | YES | NO | 1.50 | N/A | N/A | YES | NO |
Imtiaz 2010 [50] | M | 49 | NO | YES | N/A | NO | NO | NO | NO | NO | YES | <70 | 584 | N/A | YES | NO |
van Beers et al., 2011 [51] | M | 49 | NO | YES | YES | YES | NO | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Celik 2012 [52] | M | 45 | N/A | YES | YES | N/A | NO | NO | NO | NO | NO | 70 | N/A | N/A | NO | NO |
van Noord et al., 2012 [53] | M | 62 | N/A | YES | NO | NO | NO | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Kormann et al., 2012 [54] | F | 70 | N/A | YES | N/A | YES | NO | NO | YES | NO | N/A | N/A | N/A | 10000 | YES | NO |
Ruiz-Granados et al. [55] | F | 51 | NO | YES | YES | NO | NO | NO | NO | NO | YES | 113 | N/A | N/A | YES | NO |
Dehours et al., 2013 [56] | M | 35 | N/A | N/A | N/A | YES | NO | NO | NO | NO | NO | N/A | N/A | N/A | NO | NO |
Flores-Robles et al., 2013 [57] | F | 47 | NO | YES | NO | YES | NO | NO | NO | NO | YES | 40 | N/A | N/A | YES | NO |
Khan et al., 2013 [58] | F | 69 | YES | YES | YES | N/A | NO | NO | NO | NO | YES | 70 | N/A | N/A | NO | NO |
Panduranga et al., 2013 [59] | F | 38 | NO | YES | YES | YES | NO | NO | YES | YES | NO | N/A | N/A | N/A | YES | NO |
Kronborg-white 2013 [60] | M | 60 | NO | YES | YES | N/A | YES | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Horwitz et al., 2014 [61] | M | 65 | N/A | YES | YES | N/A | YES | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Cortini E. et al., 2014 [62] | F | 55 | NO | YES | NO | YES | NO | YES | NO | YES | YES | N/A | N/A | 63 | YES | NO |
De Putter et al., 2014 [63] | M | 52 | NO | YES | YES | N/A | YES | NO | NO | NO | YES | 28 | 535 | N/A | YES | NO |
Main et al., 2015 [64] | N/A | 21 | YES | YES | N/A | N/A | YES | NO | NO | NO | NO | 38 | N/A | N/A | NO | NO |
koku et al., 2015 [65] | M | 57 | NO | YES | N/A | YES | NO | NO | NO | NO | NO | 30.88 | N/A | N/A | YES | NO |
Danis et al., 2015 [66] | M | 49 | NO | YES | YES | N/A | YES | NO | NO | NO | NO | N/A | N/A | N/A | YES | NO |
Machalke et al., 2015 [67] | M | 57 | NO | YES | N/A | N/A | NO | NO | NO | NO | YES | 11,000 | 4.25 | N/A | YES | NO |
Dai et al., 2015 [68] | M | 66 | n/a | YES | YES | N/A | NO | NO | NO | NO | YES | 12.87 | N/A | N/A | YES | NO |
Hataya et al., 2015 [69] | M | 81 | NO | YES | YES | NO | YES | NO | NO | NO | YES | 61.8 | 357 | N/A | YES | NO |
Allcock et al., 2015 [70] | F | 45 | NO | N/A | N/A | NO | NO | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Caravaca-Fontan et al., 2015 [71] | M | 15 | N/A | YES | YES | YES | YES | NO | NO | YES | NO | 43.8 | 236 | N/A | YES | NO |
Tassinari et al., 2015 [72] | M | 10 | NO | NO | N/A | N/A | NO | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
O’Connell et al., 2016 [73] | F | 56 | N/A | YES | N/A | N/A | NO | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Erkus et al., 2016 [74] | M | 57 | N/A | YES | N/A | YES | NO | NO | NO | NO | NO | 171.36 | N/A | N/A | YES | NO |
Foster et al., 2017 [75] | F | 48 | NO | YES | N/A | NO | NO | NO | NO | NO | YES | <100 | N/A | N/A | YES | NO |
Foster et al., 2017 [75] | M | 51 | YES | YES | N/A | N/A | YES | NO | NO | YES | YES | 83 | N/A | N/A | YES | NO |
Mehrtash et al., 2017 [76] | M | 22 | NO | YES | N/A | YES | NO | NO | NO | NO | NO | N/A | N/A | N/A | NO | NO |
Sayiner et al., 2017 [77] | M | 43 | NO | YES | YES | N/A | YES | YES | NO | NO | NO | N/A | N/A | N/A | YES | NO |
Varma et al., 2017 [78] | F | 70 | NO | YES | N/A | NO | NO | NO | NO | NO | YES | N/A | N/A | N/A | NO | NO |
Zhong et al., 2017 [79] | M | 71 | NO | YES | N/A | N/A | YES | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Gallacher et al., 2017 [80] | M | 65 | N/A | YES | N/A | NO | YES | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Jing et al., 2018 [81] | F | 47 | N/A | YES | N/A | N/A | YES | NO | NO | NO | YES | N/A | N/A | N/A | NO | NO |
Ramchandran et al., 2018 [82] | M | 45 | YES | YES | YES | NO | YES | NO | NO | NO | YES | 43.88 | 441.44 | N/A | YES | NO |
Shin et al., 2019 [83] | F | 68 | N/A | N/A | N/A | N/A | N/A | YES | N/A | N/A | YES | N/A | N/A | N/A | YES | NO |
Smedegaard et al., 2019 [84] | F | 43 | NO | YES | N/A | YES | YES | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Falet et al., 2019 [85] | M | 84 | N/A | YES | N/A | NO | NO | NO | NO | NO | YES | 71 | N/A | N/A | YES | NO |
Attou et al., 2020 [86] | M | 45 | NO | YES | NO | YES | YES | NO | NO | NO | YES | 106 | N/A | N/A | YES | NO |
Attou et al., 2020 [86] | F | 30 | NO | YES | YES | N/A | YES | YES | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Benge et al., 2020 [87] | F | 74 | NO | YES | N/A | NO | NO | YES | NO | YES | YES | 12.87 | N/A | N/A | YES | NO |
Edelman et al., 2020 [88] | M | 54 | YES | NO | NO | YES | YES | YES | YES | NO | YES | 51.48 | N/A | N/A | YES | YES |
Kwon et al., 2020 [89] | M | 79 | NO | YES | YES | YES | NO | NO | NO | NO | YES | 24.58 | N/A | N/A | YES | NO |
Awad et al., 2020 [90] | M | 62 | NO | YES | NO | N/A | NO | NO | NO | NO | YES | 12.87 | N/A | N/A | YES | NO |
Petersen et al., 2020 [91] | F | 77 | YES | YES | N/A | YES | NO | NO | NO | NO | YES | 39 | N/A | N/A | YES | NO |
Jing et al., 2020 [92] | M | 59 | YES | YES | NO | N/A | NO | NO | NO | NO | YES | N/A | N/A | N/A | NO | NO |
Patel et al., 2021 [93] | M | 61 | NO | YES | N/A | YES | YES | NO | NO | YES | YES | 38.61 | 606.98 | N/A | YES | NO |
McHugh J. et al., 2021 [94] | F | 79 | NO | YES | YES | YES | YES | NO | YES | NO | YES | 2600 | N/A | N/A | YES | NO |
Khan et al., 2022 [58] | M | 56 | NO | YES | YES | N/A | YES | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Shibata et al., 2022 [95] | F | 87 | NO | YES | YES | YES | NO | NO | NO | NO | YES | 92.5 | N/A | N/A | YES | NO |
Bettini et al., 2022 [96] | F | 84 | YES | YES | N/A | YES | YES | YES | NO | NO | YES | 66.07 | N/A | N/A | YES | NO |
Yoshida et al., 2022 [97] | F | 84 | NO | YES | YES | YES | YES | NO | YES | NO | YES | N/A | N/A | N/A | YES | YES |
Blanpain 2023 [98] | M | 49 | N/A | YES | N/A | NO | NO | NO | NO | NO | YES | N/A | N/A | N/A | YES | NO |
Han et al., 2023 [99] | F | 89 | N/A | YES | N/A | YES | N/A | N/A | YES | NO | N/A | 706 | N/A | N/A | YES | NO |
Molina-Lopez et al., 2023 [100] | M | 95 | YES | YES | N/A | YES | NO | NO | YES | YES | YES | 12.87 | N/A | N/A | YES | NO |
Ceccuzzi et al., 2023 [101] | F | 38 | NO | YES | YES | YES | YES | YES | NO | YES | YES | 24.45 | 817.26 | 115 | YES | NO |
Note. GI disorders: Abdominal tenderness, Nausea, Vomiting, Diarrhoea; Hypernatremia: Na Serum Concentration > 145 Mmol/L; Hypokalemia: K Serum Concentration < 3.6 Mmol/L; Metabolic Alkalosis: Serum pH > 7.45; Muscle Symptoms: Spams, Fasciculations, Myoclonus, Rhabdomyolysis, Fatigue; Neurological Symptoms: GCS < 15, Epileptiform Manifestations, Visual impairment due to retinic and occipital vasospasm, paresis, cerebral microhemorrhages, licorice induced myoclonus; MACEs: Major Cardiac Events; Hypertension: Systolic BP > 140 mmHg, Diastolic BP > 90 mmHg, cardiac arrest, heart failure and pulmonary edema, Cardiac arrhythmias and death due to QT prolongation, hypertensive encephalopathy, embolic ischemia, hypertensive retinopathy; Serum GA levels (ng/mL).